Modus Therapeutics Holding AB Stock price
Equities
MODTX
SE0015987904
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 SEK | +1.33% | -9.16% | -34.29% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 40.97M 438M |
---|---|---|---|---|---|
Net income 2024 * | -27M -289M | Net income 2025 * | -37M -396M | EV / Sales 2024 * | - |
Net cash position 2024 * | 13M 139M | Net cash position 2025 * | 47M 503M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.5
x | P/E ratio 2025 * |
-1.08
x | Employees | 2 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 9.89% |
1 day | +1.33% | ||
1 week | -9.16% | ||
Current month | -32.74% | ||
1 month | -33.33% | ||
3 months | -34.48% | ||
6 months | -42.42% | ||
Current year | -34.29% |
Managers | Title | Age | Since |
---|---|---|---|
John Öhd
CEO | Chief Executive Officer | 53 | 19-12-31 |
Claes Lindblad
DFI | Director of Finance/CFO | 57 | 21-03-14 |
Ellen Donnelly
BRD | Director/Board Member | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Viktor Drvota
CHM | Chairman | 59 | 15-12-31 |
Director/Board Member | 65 | 13-12-31 | |
Ellen Donnelly
BRD | Director/Board Member | 50 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.14 | +1.33% | 36 360 |
24-03-27 | 1.125 | +1.35% | 5,989 |
24-03-26 | 1.11 | -1.77% | 35,099 |
24-03-25 | 1.13 | -9.24% | 52,111 |
24-03-22 | 1.245 | -0.80% | 162,762 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:38 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.29% | 3.81M | |
+9.56% | 45.97B | |
+52.73% | 43.93B | |
+7.22% | 42.34B | |
-8.78% | 28.27B | |
+18.23% | 27.18B | |
-21.56% | 19.44B | |
+14.59% | 13.83B | |
+32.39% | 12.4B | |
+5.45% | 11.45B |